Festival della Salute: conference on self-sufficiency supported by Kedrion
Plasma and plasma-derived products take centre stage at a workshop with all the stakeholders of the Italian Blood System
Counterfeit RhoGAM Ultra-Filtered PLUS used for preventing HDN found in India
Johnson & Johnson Limited has identified counterfeit RhoGAM Ultra-Filtered PLUS in the state of West Bengal and Uttar Pradesh in India. This issue does not involve any other product manufactured or distributed by Ortho Clinical Diagnostics or Kedrion Biopharma India Pvt. Ltd.
Kedrion, one of Italy’s most innovative companies in 2014
The MIT Technology Review Italia’s award given in Bologna in mid-May
5-year unrated EUR 300 million bond successfully launched
The bonds have been placed with leading international institutional investors and will be listed on the Irish Stock Exchange
Kedrion Group approves 2013 financial statements
Achieved results of 425 million euros turnover and a 25% profitability
Kedrion collection centers first to be certified in Hungary
Plazmaferezis Állomás Kft achieves international PPTA certification
Award in the US for efforts to support hemophilia patients communities
Kedrion’s Vice-President of North American Commercial Operations is “Man of the Year” for the Hemophilia Association of New Jersey
Conference in Colombia: Professor Mannucci on the future of hemophilia
The event, open to industry experts, patients’ associations and the scientific community, took place in Medellín on February 12th, 2014
Distribution of the first recombinant Factor VIII from human cells
Kedrion to be the distributor in Italy over the next ten years. The indication is the treatment of…
Kedrion and La Kelley Communication for a donation in Pakistan
500,000 IU of Factor IX shipped to the Pakistan Hemophilia Patients Welfare Society Rawalpindi.